This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may vary substantially as a result of a variety of factors. Among the important factors that could cause actual results to differ are, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, the results of the validation testing of the BSM-2000 undertaken by an independent third party, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products and do so on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions. These and other risk factors are discussed in our periodic reports filed with the SEC, including our Report on Form 10-K for the year ended December 31, 2004 and our periodic Reports on Form 10-Q for the quarters ended March 31, 2005, June 30, 2005, and September 30, 2005 and the reader is directed to these statements for a further discussion of important factors that could cause actual results to differ materially from those in the forward-looking statements.
CONTACT: Universal Detection Technology Jacques Tizabi, 310-248-3655 firstname.lastname@example.org or Financial Communications Trilogy Capital Partners Paul Karon, 800-592-6067 email@example.com KEYWORD: CALIFORNIA UNITED KINGDOM INTERNATIONAL EUROPEINDUSTRY KEYWORD: HARDWARE MEDICAL AEROSPACE/DEFENSE GOVERNMENT BIOTECHNOLOGY TRADESHOW PRODUCTSOURCE: Universal Detection Technology
<<Business Wire -- 12/02/05>>